Cala kIQ Plus: The First Wearable Neurostimulator With Multiple Waveform Modes Goes National
The FDA-cleared Cala kIQ Plus is now available across the US: the first wearable with multiple stimulation waveform modes for action hand tremor.
Battery-Free Brain Implant Leaves the Lab: ABILITY Neurotech's ALS Trial
ABILITY Neurotech's optical-link BCI received approval for chronic home use in ALS patients — the first time this class of device moves from controlled demonstrations to real-world daily use.
Inbrain's Graphene Brain Interface: First Human Trial Results Signal a New Class of Neural Device
Inbrain's graphene cortical interface completed its first 8-patient human trial with no device-related adverse events — a safety milestone for a neural recording technology designed to be thinner and more biocompatible than conventional silicon.
Sensory Stimulation Architecture: Cognito's $105M Cognitive Longevity Play
Cognito Therapeutics secures $105M to advance its non-invasive sensory stimulation therapy, marking a shift in Alzheimer's treatment architecture from chemical to electrical intervention.
Gamma-Band Modulation: The Hardware-Software Convergence in Cognitive Longevity
Analyzing the Spectris platform's use of sensory-driven gamma oscillations to preserve neural architecture and cognitive function.